AzTrials
AzTrials

Thoracic AnesthesiaNCT07329855

Opioid Consumption After Thoracotomy and Factors Affecting Postoperative Acute Pain

An observational study of Thoracic Anesthesia and Thoracotomy, run by Ankara Ataturk Sanatorium Training and Research Hospital at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Thoracic surgery operations constitute a significant portion of surgical procedures performed in hospitals. In the United States, more than 50,000 thoracic surgical procedures are performed annually, and more than 80% of these patients experience moderate to severe postoperative pain requiring opioid administration… Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Thoracic Anesthesia, Thoracotomy, Opioid
What is being tested?
Opioid Analgesic and Pain Medicine
How many people
35 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 Jan 2026to 5 May 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: This study will begin prospectively and will be completed once the targeted number of patients has been reached. The study population will consist of patients over 18 years of age who are scheduled to undergo thoracotomy under general anesthesia at the operating rooms of the Department of Anesthesiology and Reanimation, University of Health Sciences, Ankara Atatürk Sanatorium Training and Research Hospital.

Who may be able to join

  • Patients aged over 18 years
  • Patients scheduled for thoracotomy
  • Patients with an American Society of Anesthesiologists (ASA) physical status classification of I-III
  • Patients who have provided informed consent
  • Patients with a body mass index (BMI) between 18-40 kg/m²

Who cannot join

  • Patients with ASA class IV or higher
  • Patients younger than 18 years old
  • Patients with systemic inflammatory disease
  • Patients receiving continuous anti-inflammatory and/or analgesic medication
  • Patients with chronic preoperative pain
  • Pregnant patients
Show all 12Show fewer
  • Outpatients who received anesthesia outside the operating room
  • Emergency cases
  • Patients who underwent VATS, sternotomy, mediastinoscopy, or tracheal resection
  • Patients with a history of previous thoracic surgery
  • Patients who had a thoracic epidural catheter inserted for postoperative pain management
  • Patients with a BMI <18 or >40 kg/m²

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara Ataturk Sanatorium Training and Research Hospital, Ankara, 06280

    Ankara

Other trials in Turkey (Türkiye)

About this study

Official title: Analysis of Opioid Consumption After Thoracotomy and Factors Affecting Postoperative Acute Pain

Thoracic surgery operations constitute a significant portion of surgical procedures performed in hospitals. In the United States, more than 50,000 thoracic surgical procedures are performed annually, and more than 80% of these patients experience moderate to severe postoperative pain requiring opioid administration, which increases the risk of complications . It has also been reported that chronic pain develops in approximately 50% of patients after thoracic surgery .

Thoracic surgery is commonly associated with severe, multifactorial pain during the postoperative period and is among the surgical branches with a high risk of developing chronic pain Despite advances in understanding postoperative pain mechanisms and improvements in pain management, inadequate postoperative pain control remains an unresolved healthcare problem. Higher acute pain scores are associated with less effective ventilation and coughing, increased incidence of lower respiratory tract infections, and prolonged ICU and hospital stays .

Read more

In the management of acute postoperative pain after thoracic surgery, clinicians have sought alternatives to thoracic epidural analgesia to avoid its potential adverse effects. Truncal blocks such as thoracic paravertebral block, erector spinae plane block, and serratus anterior block have been used to reduce postoperative pain . Additionally, various other analgesic techniques such as patient-controlled analgesia (PCA) and multimodal analgesia have been employed. Historically, the cornerstone of acute postoperative pain control has been systemic opioids administered via oral, intravenous, or thoracic epidural routes . Although opioids provide excellent pain relief, they are associated with significant side effects that can adversely affect recovery .

With the increasing use of ultrasonography (USG), truncal blocks have become more widespread. Alongside the development of Enhanced Recovery After Thoracic Surgery (ERATS) protocols, efforts have been made to reduce opioid use, leading to differing opinions regarding the management of acute pain after thoracic surgery. To prevent opioid use disorder and potential side effects, opioid-free or opioid-sparing approaches are now being encouraged in perioperative pain management . Conversely, some studies suggest that intraoperative opioid administration may have favorable effects on postoperative acute and chronic pain. Previous research has reported that the average daily opioid consumption after thoracic surgery is approximately 30 morphine milligram equivalents (MME) .

Although video-assisted thoracoscopic surgery (VATS) has become more common, thoracotomy cases still constitute a large proportion of thoracic surgery procedures. Moreover, severe postoperative pain after thoracic surgery is most commonly associated with the thoracotomy incision itself. While some studies have suggested that new truncal block techniques may provide effective analgesia and reduce opioid consumption after thoracotomy, further studies are needed to determine which blocks are most commonly preferred and how opioid consumption patterns have changed with the adoption of these newer regional techniques.

A review of the current literature reveals that the factors influencing acute pain after thoracotomy have not been sufficiently evaluated. Therefore, a re-evaluation of the factors affecting acute pain following thoracotomy, considering recent developments in pain management, is necessary. Furthermore, examining the relationship between perioperative opioid consumption, postoperative complications, and hospital length of stay in this patient population will provide valuable contributions to the literature.

The aim of this study is to evaluate the amount of opioid consumption following thoracotomy and to investigate whether perioperative opioid use affects acute pain, postoperative complications, and the length of hospital stay.

Read the detailed description

H₀ (Null Hypothesis):

Opioid consumption in patients after thoracotomy is not high (≤30 morphine milligram equivalents [MME]/day).

H₁ (Alternative Hypothesis):

Opioid consumption in patients after thoracotomy is high (>30 morphine milligram equivalents [MME]/day).

Being tested
Opioid Analgesic, Pain Medicine
Keywords
Thoracotomy, opioid consumption, postoperative acute pain, postoperative complications, length of hospital stay
Medical subject headings
Pain, Postoperative, Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Opioid AnalgesicOther

    The total intraoperative and postoperative opioid consumption will be determined. The effect of perioperative opioid use on postoperative acute pain, postoperative complications, and length of hospital stay will be investigated.

  • Pain MedicineOther

    Pain levels of patients at 1, 2, 4, 8, 16, 24, and 48 hours after thoracotomy will be evaluated using the Visual Analog Scale (VAS).

Study groups in NCT07329855
Study groupRoleWhat they receive
Patients aged over 18 years old scheduled for thoracotomyThe total intraoperative and postoperative opioid consumption will be determined. The effect of perioperative opioid use on postoperative acute pain, postoperative complications, and length of hospital stay will be investigated.
Receives: Other: Opioid Analgesic; Other: Pain Medicine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. opioid consumption

    Measured: intraoperatively and for 24 hours postoperatively

  2. Determination of the amount of opioid consumption after thoracotomy

    Measured: 24 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jan 2026
  2. Study start5 Jan 2026
  3. Primary completion6 Apr 2026
  4. Study completion5 May 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
35 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07329855
Sponsor's protocol ID
2024-KAEK-24/23
Status last verified
Jan 2026
First submitted
29 Dec 2025
Last updated
3 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Thoracic Anesthesia and Thoracotomy, run by Ankara Ataturk Sanatorium Training and Research Hospital at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

opioid consumption (time frame: intraoperatively and for 24 hours postoperatively). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in